Skip to main content
Top
Published in: Diabetologia 7/2017

01-07-2017 | Article

Fatty acid status in infancy is associated with the risk of type 1 diabetes-associated autoimmunity

Authors: Sari Niinistö, Hanna-Mari Takkinen, Iris Erlund, Suvi Ahonen, Jorma Toppari, Jorma Ilonen, Riitta Veijola, Mikael Knip, Outi Vaarala, Suvi M. Virtanen

Published in: Diabetologia | Issue 7/2017

Login to get access

Abstract

Aims/hypothesis

We investigated the association of early serum fatty acid composition with the risk of type 1 diabetes-associated autoimmunity. Our hypothesis was that fatty acid status during infancy is related to type 1 diabetes-associated autoimmunity and that long-chain n-3 fatty acids, in particular, are associated with decreased risk.

Methods

We performed a nested case–control analysis within the Finnish Type 1 Diabetes Prediction and Prevention Study birth cohort, carrying HLA-conferred susceptibility to type 1 diabetes (n = 7782). Serum total fatty acid composition was analysed by gas chromatography in 240 infants with islet autoimmunity and 480 control infants at the age of 3 and 6 months. Islet autoimmunity was defined as repeated positivity for islet cell autoantibodies in combination with at least one of three selected autoantibodies. In addition, a subset of 43 infants with primary insulin autoimmunity (i.e. those with insulin autoantibodies as the first autoantibody with no concomitant other autoantibodies) and a control group (n = 86) were analysed. A third endpoint was primary GAD autoimmunity defined as GAD autoantibody appearing as the first antibody without other concomitant autoantibodies (22 infants with GAD autoimmunity; 42 infants in control group). Conditional logistic regression was applied, considering multiple comparisons by false discovery rate <0.05.

Results

Serum fatty acid composition differed between breastfed and non-breastfed infants, reflecting differences in the fatty acid composition of the milk. Fatty acids were associated with islet autoimmunity (higher serum pentadecanoic, palmitic, palmitoleic and docosahexaenoic acids decreased risk; higher arachidonic:docosahexaenoic and n-6:n-3 acid ratios increased risk). Furthermore, fatty acids were associated with primary insulin autoimmunity, these associations being stronger (higher palmitoleic acid, cis-vaccenic, arachidonic, docosapentaenoic and docosahexaenoic acids decreased risk; higher α-linoleic acid and arachidonic:docosahexaenoic and n-6:n-3 acid ratios increased risk). Moreover, the quantity of breast milk consumed per day was inversely associated with primary insulin autoimmunity, while the quantity of cow’s milk consumed per day was directly associated.

Conclusions/interpretation

Fatty acid status may play a role in the development of type 1 diabetes-associated autoimmunity. Fish-derived fatty acids may be protective, particularly during infancy. Furthermore, fatty acids consumed during breastfeeding may provide protection against type 1 diabetes-associated autoimmunity. Further studies are warranted to clarify the independent role of fatty acids in the development of type 1 diabetes.
Appendix
Available only for authorised users
Literature
2.
go back to reference Zipris D (2013) The interplay between the gut microbiota and the immune system in the mechanism of type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 20:265–270CrossRefPubMed Zipris D (2013) The interplay between the gut microbiota and the immune system in the mechanism of type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 20:265–270CrossRefPubMed
3.
go back to reference Vehik K, Lynch KF, Schatz DA et al (2016) Reversion of β-cell autoimmunity changes risk of type 1 diabetes: TEDDY Study. Diabetes Care 39:1535–1542CrossRefPubMed Vehik K, Lynch KF, Schatz DA et al (2016) Reversion of β-cell autoimmunity changes risk of type 1 diabetes: TEDDY Study. Diabetes Care 39:1535–1542CrossRefPubMed
4.
go back to reference Calder PC (2013) N-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions. Proc Nutr Soc 72:326–336CrossRefPubMed Calder PC (2013) N-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions. Proc Nutr Soc 72:326–336CrossRefPubMed
5.
go back to reference Galli C, Calder PC (2009) Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review. Ann Nutr Metab 55:123–139CrossRefPubMed Galli C, Calder PC (2009) Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review. Ann Nutr Metab 55:123–139CrossRefPubMed
6.
go back to reference Innis SM (2011) Metabolic programming of long-term outcomes due to fatty acid nutrition in early life. Matern Child Nutr 7(Suppl 2):112–123CrossRefPubMed Innis SM (2011) Metabolic programming of long-term outcomes due to fatty acid nutrition in early life. Matern Child Nutr 7(Suppl 2):112–123CrossRefPubMed
7.
go back to reference Nauta AJ, Ben Amor K, Knol J, Garssen J, van der Beek EM (2013) Relevance of pre- and postnatal nutrition to development and interplay between the microbiota and metabolic and immune systems. Am J Clin Nutr 98:586S–593SCrossRefPubMed Nauta AJ, Ben Amor K, Knol J, Garssen J, van der Beek EM (2013) Relevance of pre- and postnatal nutrition to development and interplay between the microbiota and metabolic and immune systems. Am J Clin Nutr 98:586S–593SCrossRefPubMed
8.
go back to reference Oresic M, Gopalacharyulu P, Mykkanen J et al (2013) Cord serum lipidome in prediction of islet autoimmunity and type 1 diabetes. Diabetes 62:3268–3274CrossRefPubMedPubMedCentral Oresic M, Gopalacharyulu P, Mykkanen J et al (2013) Cord serum lipidome in prediction of islet autoimmunity and type 1 diabetes. Diabetes 62:3268–3274CrossRefPubMedPubMedCentral
9.
go back to reference Stene LC, Joner G, Norwegian Childhood Diabetes Study Group (2003) Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am J Clin Nutr 78:1128–1134PubMed Stene LC, Joner G, Norwegian Childhood Diabetes Study Group (2003) Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am J Clin Nutr 78:1128–1134PubMed
10.
go back to reference Norris JM, Yin X, Lamb MM et al (2007) Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA 298:1420–1428CrossRefPubMed Norris JM, Yin X, Lamb MM et al (2007) Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA 298:1420–1428CrossRefPubMed
11.
go back to reference Norris JM, Kroehl M, Fingerlin TE et al (2014) Erythrocyte membrane docosapentaenoic acid levels are associated with islet autoimmunity: the diabetes autoimmunity study in the young. Diabetologia 57:295–304CrossRefPubMed Norris JM, Kroehl M, Fingerlin TE et al (2014) Erythrocyte membrane docosapentaenoic acid levels are associated with islet autoimmunity: the diabetes autoimmunity study in the young. Diabetologia 57:295–304CrossRefPubMed
12.
go back to reference Virtanen SM, Niinisto S, Nevalainen J et al (2010) Serum fatty acids and risk of advanced β-cell autoimmunity: a nested case-control study among children with HLA-conferred susceptibility to type I diabetes. Eur J Clin Nutr 64:792–799CrossRefPubMed Virtanen SM, Niinisto S, Nevalainen J et al (2010) Serum fatty acids and risk of advanced β-cell autoimmunity: a nested case-control study among children with HLA-conferred susceptibility to type I diabetes. Eur J Clin Nutr 64:792–799CrossRefPubMed
13.
go back to reference Miller MR, Yin X, Seifert J, Clare-Salzler M et al (2011) Erythrocyte membrane omega-3 fatty acid levels and omega-3 fatty acid intake are not associated with conversion to type 1 diabetes in children with islet autoimmunity: the diabetes autoimmunity study in the young (DAISY). Pediatr Diabetes 12:669–675CrossRefPubMedPubMedCentral Miller MR, Yin X, Seifert J, Clare-Salzler M et al (2011) Erythrocyte membrane omega-3 fatty acid levels and omega-3 fatty acid intake are not associated with conversion to type 1 diabetes in children with islet autoimmunity: the diabetes autoimmunity study in the young (DAISY). Pediatr Diabetes 12:669–675CrossRefPubMedPubMedCentral
14.
go back to reference Sorensen IM, Joner G, Jenum PA, Eskild A, Stene LC (2012) Serum long chain n-3 fatty acids (EPA and DHA) in the pregnant mother are independent of risk of type 1 diabetes in the offspring. Diabetes Metab Res Rev 28:431–438CrossRefPubMed Sorensen IM, Joner G, Jenum PA, Eskild A, Stene LC (2012) Serum long chain n-3 fatty acids (EPA and DHA) in the pregnant mother are independent of risk of type 1 diabetes in the offspring. Diabetes Metab Res Rev 28:431–438CrossRefPubMed
15.
go back to reference Niinisto S, Takkinen HM, Uusitalo L et al (2014) Maternal dietary fatty acid intake during pregnancy and the risk of preclinical and clinical type 1 diabetes in the offspring. Br J Nutr 111:895–903CrossRefPubMed Niinisto S, Takkinen HM, Uusitalo L et al (2014) Maternal dietary fatty acid intake during pregnancy and the risk of preclinical and clinical type 1 diabetes in the offspring. Br J Nutr 111:895–903CrossRefPubMed
16.
go back to reference Stene LC, Ulriksen J, Magnus P, Joner G (2000) Use of cod liver oil during pregnancy associated with lower risk of type I diabetes in the offspring. Diabetologia 43:1093–1098CrossRefPubMed Stene LC, Ulriksen J, Magnus P, Joner G (2000) Use of cod liver oil during pregnancy associated with lower risk of type I diabetes in the offspring. Diabetologia 43:1093–1098CrossRefPubMed
17.
go back to reference Virtanen SM, Nevalainen J, Kronberg-Kippila C et al (2012) Food consumption and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes: a nested case-control design. Am J Clin Nutr 95:471–478CrossRefPubMed Virtanen SM, Nevalainen J, Kronberg-Kippila C et al (2012) Food consumption and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes: a nested case-control design. Am J Clin Nutr 95:471–478CrossRefPubMed
18.
go back to reference Norris JM, Barriga K, Klingensmith G et al (2003) Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 290:1713–1720CrossRefPubMed Norris JM, Barriga K, Klingensmith G et al (2003) Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 290:1713–1720CrossRefPubMed
19.
go back to reference Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E (2003) Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 290:1721–1728CrossRefPubMed Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E (2003) Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 290:1721–1728CrossRefPubMed
20.
go back to reference Virtanen SM, Takkinen HM, Nevalainen J, Kronberg-Kippila C et al (2011) Early introduction of root vegetables in infancy associated with advanced ss-cell autoimmunity in young children with human leukocyte antigen-conferred susceptibility to type 1 diabetes. Diabet Med 28:965–971CrossRefPubMed Virtanen SM, Takkinen HM, Nevalainen J, Kronberg-Kippila C et al (2011) Early introduction of root vegetables in infancy associated with advanced ss-cell autoimmunity in young children with human leukocyte antigen-conferred susceptibility to type 1 diabetes. Diabet Med 28:965–971CrossRefPubMed
21.
go back to reference Virtanen SM, Hypponen E, Laara E et al (1998) Cowʼs milk consumption, disease-associated autoantibodies and type 1 diabetes mellitus: a follow-up study in siblings of diabetic children. Childhood diabetes in Finland study group. Diabet Med 15:730–738CrossRefPubMed Virtanen SM, Hypponen E, Laara E et al (1998) Cowʼs milk consumption, disease-associated autoantibodies and type 1 diabetes mellitus: a follow-up study in siblings of diabetic children. Childhood diabetes in Finland study group. Diabet Med 15:730–738CrossRefPubMed
22.
go back to reference Virtanen SM, Laara E, Hypponen E et al (2000) Cow’s milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group. Diabetes 49:912–917 Virtanen SM, Laara E, Hypponen E et al (2000) Cow’s milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group. Diabetes 49:912–917
23.
go back to reference Wahlberg J, Vaarala O, Ludvigsson J, ABIS-study group (2006) Dietary risk factors for the emergence of type 1 diabetes-related autoantibodies in 21/2 year-old Swedish children. Br J Nutr 95:603–608CrossRefPubMed Wahlberg J, Vaarala O, Ludvigsson J, ABIS-study group (2006) Dietary risk factors for the emergence of type 1 diabetes-related autoantibodies in 21/2 year-old Swedish children. Br J Nutr 95:603–608CrossRefPubMed
24.
go back to reference Lamb MM, Miller M, Seifert JA et al (2015) The effect of childhood cowʼs milk intake and HLA-DR genotype on risk of islet autoimmunity and type 1 diabetes: the diabetes autoimmunity study in the young. Pediatr Diabetes 16:31–38CrossRefPubMed Lamb MM, Miller M, Seifert JA et al (2015) The effect of childhood cowʼs milk intake and HLA-DR genotype on risk of islet autoimmunity and type 1 diabetes: the diabetes autoimmunity study in the young. Pediatr Diabetes 16:31–38CrossRefPubMed
25.
26.
27.
go back to reference Vaarala O, Ilonen J, Ruohtula T et al (2012) Removal of bovine insulin from cowʼs milk formula and early initiation of beta-cell autoimmunity in the FINDIA pilot study. Arch Pediatr Adolesc Med 166:608–614CrossRefPubMed Vaarala O, Ilonen J, Ruohtula T et al (2012) Removal of bovine insulin from cowʼs milk formula and early initiation of beta-cell autoimmunity in the FINDIA pilot study. Arch Pediatr Adolesc Med 166:608–614CrossRefPubMed
28.
go back to reference Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2:1279–1283CrossRefPubMed Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2:1279–1283CrossRefPubMed
29.
go back to reference Williams AJ, Bingley PJ, Bonifacio E, Palmer JP, Gale EA (1997) A novel micro-assay for insulin autoantibodies. J Autoimmun 10:473–478CrossRefPubMed Williams AJ, Bingley PJ, Bonifacio E, Palmer JP, Gale EA (1997) A novel micro-assay for insulin autoantibodies. J Autoimmun 10:473–478CrossRefPubMed
30.
go back to reference Ronkainen MS, Hamalainen AM, Koskela P, Akerblom HK, Knip M, Finnish Trigr Study Group (2001) Pregnancy induces nonimmunoglobulin insulin-binding activity in both maternal and cord blood serum. Clin Exp Immunol 124:190–196CrossRefPubMedPubMedCentral Ronkainen MS, Hamalainen AM, Koskela P, Akerblom HK, Knip M, Finnish Trigr Study Group (2001) Pregnancy induces nonimmunoglobulin insulin-binding activity in both maternal and cord blood serum. Clin Exp Immunol 124:190–196CrossRefPubMedPubMedCentral
31.
go back to reference Petersen JS, Hejnaes KR, Moody A et al (1994) Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43:459–467CrossRefPubMed Petersen JS, Hejnaes KR, Moody A et al (1994) Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43:459–467CrossRefPubMed
32.
go back to reference Savola K, Sabbah E, Kulmala P, Vahasalo P, Ilonen J, Knip M (1998) Autoantibodies associated with type I diabetes mellitus persist after diagnosis in children. Diabetologia 41:1293–1297CrossRefPubMed Savola K, Sabbah E, Kulmala P, Vahasalo P, Ilonen J, Knip M (1998) Autoantibodies associated with type I diabetes mellitus persist after diagnosis in children. Diabetologia 41:1293–1297CrossRefPubMed
33.
go back to reference Savola K, Bonifacio E, Sabbah E et al (1998) IA-2 antibodies—a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood diabetes in Finland study group. Diabetologia 41:424–429CrossRefPubMed Savola K, Bonifacio E, Sabbah E et al (1998) IA-2 antibodies—a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood diabetes in Finland study group. Diabetologia 41:424–429CrossRefPubMed
34.
go back to reference Kimpimaki T, Kulmala P, Savola K et al (2000) Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. Childhood diabetes in Finland study group. J Clin Endocrinol Metab 85:1126–1132PubMed Kimpimaki T, Kulmala P, Savola K et al (2000) Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. Childhood diabetes in Finland study group. J Clin Endocrinol Metab 85:1126–1132PubMed
35.
go back to reference Schoen S, Sichert-Hellert W, Kersting M (2009) Validation of energy requirement equations for estimation of breast milk consumption in infants. Public Health Nutr 12:2309–2316CrossRefPubMed Schoen S, Sichert-Hellert W, Kersting M (2009) Validation of energy requirement equations for estimation of breast milk consumption in infants. Public Health Nutr 12:2309–2316CrossRefPubMed
36.
go back to reference Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 57:289–300 Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 57:289–300
37.
go back to reference Uusitalo L, Nevalainen J, Salminen I et al (2013) Fatty acids in serum and diet--a canonical correlation analysis among toddlers. Matern Child Nutr 9:381–395CrossRefPubMed Uusitalo L, Nevalainen J, Salminen I et al (2013) Fatty acids in serum and diet--a canonical correlation analysis among toddlers. Matern Child Nutr 9:381–395CrossRefPubMed
38.
go back to reference Schaeffer L, Gohlke H, Muller M et al (2006) Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet 15:1745–1756CrossRefPubMed Schaeffer L, Gohlke H, Muller M et al (2006) Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet 15:1745–1756CrossRefPubMed
39.
go back to reference Standl M, Lattka E, Stach B et al (2012) FADS1 FADS2 gene cluster. PUFA intake and blood lipids in children: results from the GINIplus and LISAplus studies PLoS One 7:e37780PubMed Standl M, Lattka E, Stach B et al (2012) FADS1 FADS2 gene cluster. PUFA intake and blood lipids in children: results from the GINIplus and LISAplus studies PLoS One 7:e37780PubMed
40.
go back to reference Niinisto S, Takkinen HM, Uusitalo L et al (2015) Maternal intake of fatty acids and their food sources during lactation and the risk of preclinical and clinical type 1 diabetes in the offspring. Acta Diabetol 52:763–772CrossRefPubMed Niinisto S, Takkinen HM, Uusitalo L et al (2015) Maternal intake of fatty acids and their food sources during lactation and the risk of preclinical and clinical type 1 diabetes in the offspring. Acta Diabetol 52:763–772CrossRefPubMed
41.
go back to reference Lund-Blix NA, Stene LC, Rasmussen T, Torjesen PA, Andersen LF, Ronningen KS (2015) Infant feeding in relation to islet autoimmunity and type 1 diabetes in genetically susceptible children: the MIDIA study. Diabetes Care 38:257–263CrossRefPubMed Lund-Blix NA, Stene LC, Rasmussen T, Torjesen PA, Andersen LF, Ronningen KS (2015) Infant feeding in relation to islet autoimmunity and type 1 diabetes in genetically susceptible children: the MIDIA study. Diabetes Care 38:257–263CrossRefPubMed
42.
go back to reference Ilonen J, Hammais A, Laine AP et al (2013) Patterns of beta-cell autoantibody appearance and genetic associations during the first years of life. Diabetes 62:3636–3640CrossRefPubMedPubMedCentral Ilonen J, Hammais A, Laine AP et al (2013) Patterns of beta-cell autoantibody appearance and genetic associations during the first years of life. Diabetes 62:3636–3640CrossRefPubMedPubMedCentral
Metadata
Title
Fatty acid status in infancy is associated with the risk of type 1 diabetes-associated autoimmunity
Authors
Sari Niinistö
Hanna-Mari Takkinen
Iris Erlund
Suvi Ahonen
Jorma Toppari
Jorma Ilonen
Riitta Veijola
Mikael Knip
Outi Vaarala
Suvi M. Virtanen
Publication date
01-07-2017
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 7/2017
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-017-4280-9

Other articles of this Issue 7/2017

Diabetologia 7/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.